Aurobindo Pharma Expects to Commercialise Vaccine Facility by April-May 2021

The Hyderabad-based drug major is investing around Rs 275 crore on the facility which would be utilised to produce vaccines for the treatment of various viral diseases including COVID-19.

from Top Business News- News18.com
Read The Rest:timesnownews...
Aurobindo Pharma Expects to Commercialise Vaccine Facility by April-May 2021 Aurobindo Pharma Expects to Commercialise Vaccine Facility by April-May 2021 Reviewed by Team Exprssnews on November 29, 2020 Rating: 5

No comments:

Powered by Blogger.